A retrospective, 5‐year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs)
International Journal of Dermatology2021Vol. 60(5), pp. 579–588
Citations Over Time
Gautam K. Singh, Barnali Mitra, Sandeep Arora, Neha Akhoon, Rajesh Verma, Puja Sharma, Debdeep Mitra
Abstract
SCAR has considerable disease burden with marginal female preponderance in SJS/TEN and exfoliative dermatitis and can involve even the pediatric population. Anticonvulsants followed by antibiotics, NSAIDs, and ayurvedic medicines are common groups known to cause SCARs. To date, there are no definitive recommendations regarding their optimal treatment regimen, hence early diagnosis, prompt withdrawal of culprit drug, high standard of nursing care, and interdisciplinary consultations are vital steps to avoid disease progression and restore health.
Related Papers
- → Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis(2016)10 cited
- → Deadly drug rashes: Early recognition and multidisciplinary care(2023)3 cited
- → Pattern of Adverse Cutaneous Drug Reactions (ACDR) to Systemic Drugs(2019)
- → Acute generalized exanthematous pustulosis/exfoliative dermatitis eruption(2019)
- → Cutaneous Adverse Drug Reactions(2021)